1. Home
  2. BWBBP vs CGEN Comparison

BWBBP vs CGEN Comparison

Compare BWBBP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWBBP

Bridgewater Bancshares Inc.

N/A

Current Price

$19.15

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$1.54

Market Cap

143.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWBBP
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
325
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
143.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BWBBP
CGEN
Price
$19.15
$1.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
281.9K
Earning Date
N/A
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$231.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.13
52 Week High
N/A
$2.66

Technical Indicators

Market Signals
Indicator
BWBBP
CGEN
Relative Strength Index (RSI) 34.43 44.37
Support Level $19.60 $1.47
Resistance Level $20.10 $1.72
Average True Range (ATR) 0.32 0.09
MACD -0.13 -0.00
Stochastic Oscillator 3.53 22.01

Price Performance

Historical Comparison
BWBBP
CGEN

About BWBBP Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: